All Stories

  1. A unique electro-contact-free sensing for illegal drug methamphetamine determination by electrochemiluminescence based on wireless power transmission technology
  2. HTRA1-related cerebral small-vessel disease causes cerebral microbleeds on the brainstem surface
  3. Clinical genetic approaches to the management of patients with myotonic dystrophy type 1 and their families
  4. Functional evaluation of novel variants of B4GALNT1 in a patient with hereditary spastic paraplegia and the general population
  5. Genetic counselling for at-risk family members with hereditary transthyretin amyloidosis: data from a single-centre study
  6. Auditory Neuropathy Spectrum Disorder Progressing with Motor and Sensory Neuropathy Caused by an <i>ATP1A1</i> Variant
  7. Lysinuric protein intolerance exhibiting renal tubular acidosis/Fanconi syndrome in a Japanese woman
  8. Clinical utility of urinary mulberry bodies/cells testing in the diagnosis of Fabry disease
  9. Long-term Observation of a Japanese Patient with a Multiple-system Neurodegenerative Disorder with a Uniallelic <i>de novo</i> Missense Variant in <i>KIF1A</i>
  10. Tongue Hemiatrophy in Multifocal Motor Neuropathy
  11. Severe Cerebral Small Vessel Disease Caused by the Uniallelic p.A252T Variant ofHTRA1
  12. Clinical Features and Neuroimaging Findings of Neuropil Antibody–Positive Idiopathic Sporadic Ataxia of Unknown Etiology
  13. Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy
  14. National survey of presymptomatic genetic testing for adult-onset hereditary neuromuscular diseases—system development for after the establishment of therapies—
  15. Heterozygous missense variant in TRPC6 in a boy with rapidly progressive infantile nephrotic syndrome associated with diffuse mesangial sclerosis
  16. Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) <i>Transthyretin</i> Variant
  17. Genetic counseling and predictive testing for hereditary neuromuscular diseases
  18. A Late-onset and Relatively Rapidly Progressive Case of Pure Spinal Form Cerebrotendinous Xanthomatosis with a Novel Mutation in the <i>CYP27A1</i> Gene
  19. Elderly patient with 5q spinal muscular atrophy type 4 markedly improved by Nusinersen
  20. Intrafamilial phenotypic variation in spinocerebellar ataxia type 23
  21. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model
  22. Factors predictive of the presence of a CSF1R mutation in patients with leukoencephalopathy
  23. A novel CACNA1A nonsense variant in a patient presenting with paroxysmal exertion-induced dyskinesia
  24. Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients
  25. A novel frameshift mutation of SYNE1 in a Japanese family with autosomal recessive cerebellar ataxia type 8
  26. Inter-generational instability of inserted repeats during transmission in spinocerebellar ataxia type 31
  27. Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients
  28. Natural History of Spinocerebellar Ataxia Type 31: a 4-Year Prospective Study
  29. Hypertrophic Pachymeningitis as an Early Manifestation of Relapsing Polychondritis: Case Report and Review of the Literature
  30. Clinical assessment of standing and gait in ataxic patients using a triaxial accelerometer
  31. Response to Satomuraet al.
  32. Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation
  33. A Case Report of WEBINO Syndrome with Convergence Impairment
  34. Triple a syndrome in Japan
  35. p.E66Q mutation in theGLAgene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males
  36. Clinical and Serial MRI Findings of a Sialidosis Type I Patient with a Novel Missense Mutation in the NEU1 Gene
  37. A novel nonsense mutation in the TITF-1 gene in a Japanese family with benign hereditary chorea
  38. Adult or late-onset triple A syndrome
  39. Cerebral hemorrhage in Fabry's disease
  40. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2)
  41. Spinocerebellar ataxia type 6 (SCA6): Clinical pilot trial with gabapentin
  42. Severity and Progression Rate of Cerebellar Ataxia in 16q-linked Autosomal Dominant Cerebellar Ataxia (16q-ADCA) in the Endemic Nagano Area of Japan